Non-Covalent Active Mixing as a Viable Alternative to Covalent Conjugation for the Intracellular Delivery of Biologics: The Case of Glucarpidase
Authors:
- 1 September 2026
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (11) , 9293-9311
Abstract
No abstract availableKeywords
Funding Information
- Vice-Chancellor for Research, Shiraz University of Medical Sciences (27880)
This publication has 57 references indexed in Scilit:
- Biologics, Biosimilars, and Biobetters: Therapeutic Innovations Reshaping Modern MedicineAdvanced Biology, 2025
- Toward the Development of a Biosimilar Variant of Glucarpidase (Carboxypeptidase G2): Secretory Production, Optimization, and ImmobilizationMolecular Biotechnology, 2025
- Addressing the Blood-Brain Barrier: Overcoming Glioblastoma Drug Delivery2025
- Engineered Histidine‐Rich Peptides Enhance Endosomal Escape for Antibody‐Targeted Intracellular Delivery of Functional ProteinsAngewandte Chemie International Edition, 2023
- Tracking the Endosomal Escape: A Closer Look at Calcein and Related ReportersMacromolecular Bioscience, 2022
- Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virusInternational Journal of Peptide Research and Therapeutics, 2022
- Characterization of a Stable Form of Carboxypeptidase G2 (Glucarpidase), a Potential Biobetter Variant, From Acinetobacter sp. 263903-1Molecular Biotechnology, 2021
- Introducing a delivery system for melanogenesis inhibition in melanoma B16F10 cells mediated by the conjugation of tyrosine ammonia‐lyase and a TAT ‐penetrating peptideBiotechnology Progress, 2020
- Characterisation of the Carboxypeptidase G2 Catalytic Site and Design of New Inhibitors for Cancer TherapyChemBioChem, 2018
- The agony of choice: how to find a suitable CPP for cargo deliveryJournal of Peptide Science, 2012